Chiara Mascoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chiara Mascoli has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Mauro Gargiulo
Vascular Surgery, University of Bologna, DIMEC , Bologna
52 shared publicationsAndrea Stella
Univ Bologna, Dept Vasc Surg, Policlin S Orsola Malpighi, Via Massarenti 9, I-40138 Bologna, Italy
39 shared publications- Enrico Gallitto
Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy
39 shared publications - Gianluca Faggioli
Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy
38 shared publications - Rodolfo Pini
Vascular Surgery, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy
33 shared publications - Stefano Ancetti
Vascular Surgery, University of Bologna, Bologna, Italy
24 shared publications
Latest Publications
- Open Access
- 11 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3686
The Impact of Operator’s Learning Curve on the Outcomes of an Off-the-Shelf Multi-Branched Endograft for Complex and Thoracoabdominal Aneurysms Repair
Objectives: The study objectives are to evaluate the impact of the operator’s learning curve on the outcomes of off-the-shelf branched endovascular aortic repair (OTS-BEVAR) in complex and thoracoabdominal (C/TAAAs) aneurysms. Methods: Patients who underwent OTS-BEVAR (T-Branch, Cook-Medical) between 2013 and 2023 were considered. The first and last 25 cases with at least 1 year of follow-up were clustered in two groups (early experience: E.Exp.; late experience: L.Exp.) and compared. Technical success (TS), intraoperative target visceral vessel (TVV) loss, spinal cord ischemia (SCI), 30-day mortality, and TVV instability at 1 year were assessed as primary outcomes. Procedure/fluoroscopy time, iodinated contrast media (ICM) amount and length of hospitalization were assessed as secondary outcomes. A p value < 0.05 was considered statistically significant. Results: Overall, 106 cases were analyzed. Technical success was higher in L.Exp. than E.Exp. (L.Exp.: 25/25 vs. E.Exp.: 17/25; p: 0.004). Moreover, intraoperative TVVs loss was higher in E.Exp. than L.Exp. (E.Exp.: 12/25 vs. L.Exp.: 0/25; p: 0.0001). There were no differences in terms of 30-day/in-hospital mortality (E.Exp.:4/25 vs. L.Exp.:4/25; p: 1), SCI (E.Exp.:2/25 vs. L.Exp.:1/25; p: 1), and paraplegia (E.Exp.: 2/25 vs. L.Exp.: 0/25; p: 0.48) between E.Exp. and L.Exp. Cases of L.Exp. had lower fluoroscopy [E.Exp.: 160(21) vs. L.Exp.:72(18) min; p: 0.003] and overall procedure time [E.Exp.: 518(156) vs. L.Exp.:400(130) min; p: 0.04], ICM [EE: 220(45) vs. L.Exp.: 138(61) mL; p: 0.005] and hospitalization [E.Exp.: 17(9) vs. L.Exp.: 12(4) days; p: 0.03] than cases of E.Exp. Finally, patients managed in L.Exp. had lower TVVs instability at 12 months than patients managed in the E.Exp. (E.Exp.: 8/25 vs. L.Exp.: 1/25; p: 0.04). Conclusions: Cases managed in L.Exp. have higher TS, lower intraoperative TVVs loss and instability at 1-year than cases of E.Exp. Moreover, procedural/fluoroscopy time, ICM, radiation exposure and hospitalization are lower in L.Exp. than E.Exp.
- 11 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3686
Open AccessThe Impact of Operator’s Learning Curve on the Outcomes of an Off-the-Shelf Multi-Branched Endograft for Complex and Thoracoabdominal Aneurysms Repair
Objectives: The study objectives are to evaluate the impact of the operator’s learning curve on the outcomes of off-the-shelf branched endovascular aortic repair (OTS-BEVAR) in complex and thoracoabdominal (C/TAAAs) aneurysms. Methods: Patients who underwent OTS-BEVAR (T-Branch, Cook-Medical) between 2013 and 2023 were considered. The first and last 25 cases with at least 1 year of follow-up were clustered in two groups (early experience: E.Exp.; late experience: L.Exp.) and compared. Technical success (TS), intraoperative target visceral vessel (TVV) loss, spinal cord ischemia (SCI), 30-day mortality, and TVV instability at 1 year were assessed as primary outcomes. Procedure/fluoroscopy time, iodinated contrast media (ICM) amount and length of hospitalization were assessed as secondary outcomes. A p value < 0.05 was considered statistically significant. Results: Overall, 106 cases were analyzed. Technical success was higher in L.Exp. than E.Exp. (L.Exp.: 25/25 vs. E.Exp.: 17/25; p: 0.004). Moreover, intraoperative TVVs loss was higher in E.Exp. than L.Exp. (E.Exp.: 12/25 vs. L.Exp.: 0/25; p: 0.0001). There were no differences in terms of 30-day/in-hospital mortality (E.Exp.:4/25 vs. L.Exp.:4/25; p: 1), SCI (E.Exp.:2/25 vs. L.Exp.:1/25; p: 1), and paraplegia (E.Exp.: 2/25 vs. L.Exp.: 0/25; p: 0.48) between E.Exp. and L.Exp. Cases of L.Exp. had lower fluoroscopy [E.Exp.: 160(21) vs. L.Exp.:72(18) min; p: 0.003] and overall procedure time [E.Exp.: 518(156) vs. L.Exp.:400(130) min; p: 0.04], ICM [EE: 220(45) vs. L.Exp.: 138(61) mL; p: 0.005] and hospitalization [E.Exp.: 17(9) vs. L.Exp.: 12(4) days; p: 0.03] than cases of E.Exp. Finally, patients managed in L.Exp. had lower TVVs instability at 12 months than patients managed in the E.Exp. (E.Exp.: 8/25 vs. L.Exp.: 1/25; p: 0.04). Conclusions: Cases managed in L.Exp. have higher TS, lower intraoperative TVVs loss and instability at 1-year than cases of E.Exp. Moreover, procedural/fluoroscopy time, ICM, radiation exposure and hospitalization are lower in L.Exp. than E.Exp.
- Open Access
- 6 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7050
Operative Procedures for Ultrasound Assessment of Extracranial Artery Disease: A Narrative Review by the Italian Society for Vascular Investigation (SIDV)
Background: Duplex ultrasonography (DUS) of the extracranial arteries is essential for the primary and secondary prevention of ischemic stroke and the diagnosis of other cerebrovascular pathologies. The aim of the Italian Society for Vascular Investigation (SIDV) is to provide a standardised approach for the ultrasound evaluation of extracranial arterial disease. Methods: A multidisciplinary SIDV expert panel conducted a comprehensive literature search and performed a narrative review of the recent medical literature; the updated operative procedures were subsequently developed through a consensus-driven process that included dedicated meetings and national congress sessions for discussion and validation. Results: This document outlines a comprehensive approach to the ultrasound evaluation of extracranial arteries, detailing techniques such as Brightness Mode (B-mode), Colour Doppler, Power Doppler, contrast-enhanced ultrasound (CEUS), micro-vascular flow imaging (MVFI), and Three-Dimensional (3D) ultrasound. The text provides an in-depth discussion of clinical indications, technical protocols, plaque characterisation, stenosis quantification, and hemodynamic criteria. Emerging technologies are also examined for their potential to improve cerebrovascular risk stratification. Conclusions: The updated SIDV operative procedures for the ultrasound evaluation of extracranial cerebrovascular disease are intended to serve as a valuable reference for clinicians and vascular laboratories.
- 6 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 7050
Open AccessOperative Procedures for Ultrasound Assessment of Extracranial Artery Disease: A Narrative Review by the Italian Society for Vascular Investigation (SIDV)
Background: Duplex ultrasonography (DUS) of the extracranial arteries is essential for the primary and secondary prevention of ischemic stroke and the diagnosis of other cerebrovascular pathologies. The aim of the Italian Society for Vascular Investigation (SIDV) is to provide a standardised approach for the ultrasound evaluation of extracranial arterial disease. Methods: A multidisciplinary SIDV expert panel conducted a comprehensive literature search and performed a narrative review of the recent medical literature; the updated operative procedures were subsequently developed through a consensus-driven process that included dedicated meetings and national congress sessions for discussion and validation. Results: This document outlines a comprehensive approach to the ultrasound evaluation of extracranial arteries, detailing techniques such as Brightness Mode (B-mode), Colour Doppler, Power Doppler, contrast-enhanced ultrasound (CEUS), micro-vascular flow imaging (MVFI), and Three-Dimensional (3D) ultrasound. The text provides an in-depth discussion of clinical indications, technical protocols, plaque characterisation, stenosis quantification, and hemodynamic criteria. Emerging technologies are also examined for their potential to improve cerebrovascular risk stratification. Conclusions: The updated SIDV operative procedures for the ultrasound evaluation of extracranial cerebrovascular disease are intended to serve as a valuable reference for clinicians and vascular laboratories.
- Open Access
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
The impact of large aneurysm diameter on the outcomes of thoracoabdominal aneurysm repair by fenestrated and branched endografts
Aim of the study was to analyze the impact of preoperative thoraco-abdominal aneurysm diameter on the outcomes of fenestrated/branched endografting. Patients underwent endovascular thoraco-abdominal repair at 2 European centers (2011–2021) were analyzed. Median diameter was calculated; third quartile was considered as cut-off. Outcomes were compared in two groups based on the diameter value. Primary end-points were technical success, spinal cord ischaemia and 30-day/in-hospital mortality. Survival, freedom-from-reintervention and target-visceral-vessels instability were follow-up outcomes. Out of 247 thoraco-abdominal aortic aneurysms, the median diameter was 65 mm, first quartile was 57 mm; third quartile was 80 mm, set as cut-off value. Fifty-nine(24%) patients had diameter ≥80mm. Custom-Made and off-the-shelf branched endograft were used in 160(65%) and 87(35%), respectively. Technical success was 93% (vs ≥80mm : 94%; P:0.47). Twenty-three(9%) patients had spinal injury (vs ≥80mm : 17%; P:0.03). Twenty-two(9%) patients died within 30-day/in-hospital (vs ≥80mm : 15%; P:0.06). Multivariate analysis did not report pre-operative diameter ≥80mm as significant risk factor for primary end-points. The median follow-up was 13 (interquartile-range : 2–37) months and at 3-years survival and freedom from reintervention rates were 65% and 62%, respectively. After univariate and multivariate analysis preoperative diameter ≥80mm was considered an independent risk factor for reinterventions (HR : 1.9; 95% CI : 1.1–3.6; P:0.04), and for target visceral vessels instability (HR : 3.1; 95% CI : 1.3–5.1; P:0.04), occurred in 45(18%) cases. However after competing risk methods preoperative diameter did not show significance for follow-up results. A pre-operative thoraco-abdominal aortic aneurysm diameter greater than 80 mm has not a direct impact on early technical and clinical outcomes. Diameter ≥80mm is considered risk-factor for reinterventions and target-vessels instability considered separately during follow-up.
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
Open AccessThe impact of large aneurysm diameter on the outcomes of thoracoabdominal aneurysm repair by fenestrated and branched endografts
Aim of the study was to analyze the impact of preoperative thoraco-abdominal aneurysm diameter on the outcomes of fenestrated/branched endografting. Patients underwent endovascular thoraco-abdominal repair at 2 European centers (2011–2021) were analyzed. Median diameter was calculated; third quartile was considered as cut-off. Outcomes were compared in two groups based on the diameter value. Primary end-points were technical success, spinal cord ischaemia and 30-day/in-hospital mortality. Survival, freedom-from-reintervention and target-visceral-vessels instability were follow-up outcomes. Out of 247 thoraco-abdominal aortic aneurysms, the median diameter was 65 mm, first quartile was 57 mm; third quartile was 80 mm, set as cut-off value. Fifty-nine(24%) patients had diameter ≥80mm. Custom-Made and off-the-shelf branched endograft were used in 160(65%) and 87(35%), respectively. Technical success was 93% (vs ≥80mm : 94%; P:0.47). Twenty-three(9%) patients had spinal injury (vs ≥80mm : 17%; P:0.03). Twenty-two(9%) patients died within 30-day/in-hospital (vs ≥80mm : 15%; P:0.06). Multivariate analysis did not report pre-operative diameter ≥80mm as significant risk factor for primary end-points. The median follow-up was 13 (interquartile-range : 2–37) months and at 3-years survival and freedom from reintervention rates were 65% and 62%, respectively. After univariate and multivariate analysis preoperative diameter ≥80mm was considered an independent risk factor for reinterventions (HR : 1.9; 95% CI : 1.1–3.6; P:0.04), and for target visceral vessels instability (HR : 3.1; 95% CI : 1.3–5.1; P:0.04), occurred in 45(18%) cases. However after competing risk methods preoperative diameter did not show significance for follow-up results. A pre-operative thoraco-abdominal aortic aneurysm diameter greater than 80 mm has not a direct impact on early technical and clinical outcomes. Diameter ≥80mm is considered risk-factor for reinterventions and target-vessels instability considered separately during follow-up.
- Open Access
- 7 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4634
CO2 Angiography in the Standard and Complex Endovascular Repair of the Abdominal Aorta—A Narrative Review of the Literature
Background/Objectives: Carbon dioxide digital-subtraction angiography (CO2-DSA) is an increasingly adopted technique in endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/B-EVAR); it is used to reduce the amount of iodinate contrast medium (ICM) and prevent postoperative renal function worsening (PO-RFW). Our aim is to report results from the literature on EVAR and F/B-EVAR procedures using CO2-DSA, together with wider applications in aortic endovascular treatment. Methods: We performed a literature review by searching electronic databases for published data on CO2-DSA during EVAR and F/B-EVAR procedures. The endpoints were postoperative renal function worsening (PO-RFW) and efficacy of intraoperative arterial visualization. Further, applications of CO2 for thoracic endovascular aortic repair (TEVAR) were described. Results: Seventeen studies reporting results on CO2-DSA in EVAR (644 patients) were retrieved. Overall, 372 (58%) procedures were performed with CO2 alone, and 272 (42%) were performed with CO2+ICM. Eight studies analyzed the effect of CO2-DSA angiography on PO-RFW; four studies showed a significantly lower rate of PO-RFW compared to ICM. Five studies (153 patients) analyzed intraoperative arterial visualization with CO2-DSA; renal and hypogastric arteries were effectively visualized in 69% and 99% of cases, respectively. The use of CO2-DSA in F/B-EVAR has not been widely investigated. The largest series reported that PO-RFW was lower in the CO2 vs. ICM group. Conclusions: Carbon dioxide is widely applied in modern aortic endovascular treatment. CO2-DSA for EVAR and F/B-EVAR is an efficient technique for reducing PO-RFW while allowing acceptable arterial intraoperative visualization.
- 7 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4634
Open AccessCO2 Angiography in the Standard and Complex Endovascular Repair of the Abdominal Aorta—A Narrative Review of the Literature
Background/Objectives: Carbon dioxide digital-subtraction angiography (CO2-DSA) is an increasingly adopted technique in endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/B-EVAR); it is used to reduce the amount of iodinate contrast medium (ICM) and prevent postoperative renal function worsening (PO-RFW). Our aim is to report results from the literature on EVAR and F/B-EVAR procedures using CO2-DSA, together with wider applications in aortic endovascular treatment. Methods: We performed a literature review by searching electronic databases for published data on CO2-DSA during EVAR and F/B-EVAR procedures. The endpoints were postoperative renal function worsening (PO-RFW) and efficacy of intraoperative arterial visualization. Further, applications of CO2 for thoracic endovascular aortic repair (TEVAR) were described. Results: Seventeen studies reporting results on CO2-DSA in EVAR (644 patients) were retrieved. Overall, 372 (58%) procedures were performed with CO2 alone, and 272 (42%) were performed with CO2+ICM. Eight studies analyzed the effect of CO2-DSA angiography on PO-RFW; four studies showed a significantly lower rate of PO-RFW compared to ICM. Five studies (153 patients) analyzed intraoperative arterial visualization with CO2-DSA; renal and hypogastric arteries were effectively visualized in 69% and 99% of cases, respectively. The use of CO2-DSA in F/B-EVAR has not been widely investigated. The largest series reported that PO-RFW was lower in the CO2 vs. ICM group. Conclusions: Carbon dioxide is widely applied in modern aortic endovascular treatment. CO2-DSA for EVAR and F/B-EVAR is an efficient technique for reducing PO-RFW while allowing acceptable arterial intraoperative visualization.
- 4 March 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 31 (6) , 1130-1139
Morphological and Clinical Predictors of Early/Follow-up Failure of the Endovascular Infrarenal Abdominal Aneurysm Repair With Currently Available Endografts
Purpose: To report outcomes of endovascular repair (EVAR) of infrarenal abdominal aortic aneurysms (AAAs) with currently-available endografts and identify predictors of technical/clinical failure. Materials and Methods: Patients undergoing EVAR between 2012 and 2020 were prospectively collected and retrospectively analyzed. Technical success (TS: no type I–III endoleaks, renal/hypogastric arteries loss, iliac leg occlusion, conversion to open repair and mortality within 24 postoperative hour), proximal neck–related TS (nr-TS: no proximal type I endoleaks, unplanned renal arteries coverage), and 30-day mortality were assessed as early outcomes. Proximal type I endoleak (ELIa), survival and freedom from reinterventions (FFRs) were assessed during follow-up. Uni/multivariate analysis and Cox-regression were used to identified factors associated with early and follow-up outcomes; FFR and survival were assessed by Kaplan-Meier analysis. Results: A total of 710 were included. Technical success and nr-TS were 692 (98%) and 700 (99%), respectively. The presence of ≥2 hostile anatomical infrarenal neck characteristics was associated with technical failure (odds ratio [OR]: 2.4; 95% confidence interval [CI]: 1.3–4.1; p: 0.007). Infrarenal neck angle >90° (OR: 2.88; 95% CI: 9.6–50.3; p: 0.004), barrel shape (OR: 2.33; 95% CI: 11.1–100.3; p: 0.02) or presence of ≥2 hostile anatomical infrarenal neck characteristics (OR: 2.16; 95% CI: 2.5–5.3; p: 0.03) were independent risk factors for neck-related technical failures. Six (0.8%) patients died within 30 postoperative days. Chronic obstructive pulmonary disease (OR: 16; 95% CI: 1.1–218.3; p: 0.04) and urgent repair (OR: 15; 95% CI: 1.8–119.6; p: 0.01) were independent risk factors for 30-day mortality. The mean follow-up was 53±13 months. There were 12 (1.7%) ELIa during follow-up. Infrarenal neck length 28 mm (HR: 2.7; 95% CI: 1.6–9.5; p: 0.006), angle ≥90° (HR: 2.7; 95% CI: 8.3–50.1; p: 0.007), and persistent type II endoleak (HR: 2.9; 95% CI: 1.6–10.1; p: 0.004) were independent risk factors for ELIa. Freedom from reintervention was 91% at 5 years. The ELIa was an independent risk factor for reinterventions during follow-up (HR: 29.5; 95% CI: 1.4–1.6; p<0.001). Survival was 74% at 5 years with 2 cases (0.3%) of late aortic-related mortality. Peripheral arterial occlusive disease (HR: 1.9; 95% CI: 1.4–3.65; p: 0.03), aneurysm diameter ≥65 mm (HR: 2.2; 95% CI: 1.4–3.26; p<0.001), and infrarenal neck length <15 mm (HR: 1.7; 95% CI: 1.2–2.35; p: 0.04) were independent risk factors for mortality during follow-up. Conclusion: Endovascular repair with currently-available endografts has high TS and low 30-day mortality. Survival and FFRs were satisfactory at mid-term. Pre/postoperative risk factors for technical and clinical failure were identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome. Clinical Impact: Pre and postoperative risk factors for technical and clinical EVAR failure can be identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome.
- 4 March 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 31 (6) , 1130-1139
Morphological and Clinical Predictors of Early/Follow-up Failure of the Endovascular Infrarenal Abdominal Aneurysm Repair With Currently Available Endografts
Purpose: To report outcomes of endovascular repair (EVAR) of infrarenal abdominal aortic aneurysms (AAAs) with currently-available endografts and identify predictors of technical/clinical failure. Materials and Methods: Patients undergoing EVAR between 2012 and 2020 were prospectively collected and retrospectively analyzed. Technical success (TS: no type I–III endoleaks, renal/hypogastric arteries loss, iliac leg occlusion, conversion to open repair and mortality within 24 postoperative hour), proximal neck–related TS (nr-TS: no proximal type I endoleaks, unplanned renal arteries coverage), and 30-day mortality were assessed as early outcomes. Proximal type I endoleak (ELIa), survival and freedom from reinterventions (FFRs) were assessed during follow-up. Uni/multivariate analysis and Cox-regression were used to identified factors associated with early and follow-up outcomes; FFR and survival were assessed by Kaplan-Meier analysis. Results: A total of 710 were included. Technical success and nr-TS were 692 (98%) and 700 (99%), respectively. The presence of ≥2 hostile anatomical infrarenal neck characteristics was associated with technical failure (odds ratio [OR]: 2.4; 95% confidence interval [CI]: 1.3–4.1; p: 0.007). Infrarenal neck angle >90° (OR: 2.88; 95% CI: 9.6–50.3; p: 0.004), barrel shape (OR: 2.33; 95% CI: 11.1–100.3; p: 0.02) or presence of ≥2 hostile anatomical infrarenal neck characteristics (OR: 2.16; 95% CI: 2.5–5.3; p: 0.03) were independent risk factors for neck-related technical failures. Six (0.8%) patients died within 30 postoperative days. Chronic obstructive pulmonary disease (OR: 16; 95% CI: 1.1–218.3; p: 0.04) and urgent repair (OR: 15; 95% CI: 1.8–119.6; p: 0.01) were independent risk factors for 30-day mortality. The mean follow-up was 53±13 months. There were 12 (1.7%) ELIa during follow-up. Infrarenal neck length 28 mm (HR: 2.7; 95% CI: 1.6–9.5; p: 0.006), angle ≥90° (HR: 2.7; 95% CI: 8.3–50.1; p: 0.007), and persistent type II endoleak (HR: 2.9; 95% CI: 1.6–10.1; p: 0.004) were independent risk factors for ELIa. Freedom from reintervention was 91% at 5 years. The ELIa was an independent risk factor for reinterventions during follow-up (HR: 29.5; 95% CI: 1.4–1.6; p<0.001). Survival was 74% at 5 years with 2 cases (0.3%) of late aortic-related mortality. Peripheral arterial occlusive disease (HR: 1.9; 95% CI: 1.4–3.65; p: 0.03), aneurysm diameter ≥65 mm (HR: 2.2; 95% CI: 1.4–3.26; p<0.001), and infrarenal neck length <15 mm (HR: 1.7; 95% CI: 1.2–2.35; p: 0.04) were independent risk factors for mortality during follow-up. Conclusion: Endovascular repair with currently-available endografts has high TS and low 30-day mortality. Survival and FFRs were satisfactory at mid-term. Pre/postoperative risk factors for technical and clinical failure were identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome. Clinical Impact: Pre and postoperative risk factors for technical and clinical EVAR failure can be identified and they should be considered in EVAR indication and postoperative management to reduce complications and improve mid-term outcome.
- 23 March 2022
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 30 (3) , 410-418
Endovascular Treatment of Abdominal Aortic Aneurysm With Severe Angulation of Infrarenal Aortic Neck by Gore Conformable Endograft
Introduction: The aim of the study is to report a single-center experience with the Gore Excluder conformable endograft with active control system (CEXC Device, W.L. Gore and Associates, Flagstaff, AZ, USA) in abdominal aortic aneurysms (AAAs) with severe infrarenal neck angulation. Methods: All patients underwent EVAR with CEXC Device between September 2018 and 2020, were prospectively enrolled, and retrospectively analyzed. Anatomical details of the proximal aortic neck were evaluated. Early endpoints were the use of repositionability and angulation system, intraoperative unplanned cuff, technical success (TS), 30-day morbidity/mortality, and reintervention. Follow-up endpoints were type-I endoleaks, endograft migration, aortic neck dilatation, aneurismal sac shrinkage, survival (S), and freedom from reintervention (FFR). Results: Twenty-five patients were enrolled (median age: 80 [range = 60-90] years, median AAA diameter: 60 [range = 52-90] mm). All patients had severe infrarenal neck angulation (beta angle ≧ 60°), and 11 (44%) of those had neck beta angle ≧ 90°. Median infrarenal neck angle, length, and diameter were 70° (range = 60°-90°), 22 (range = 13-42) mm and 22 (range = 18-31) mm, respectively. Endograft repositioning system was employed in 15 (60%) cases and the median number of repositioning maneuvers was 1 (range:0-4). Active angulation system was used in 17 (68%) patients. The median proximal diameter of the main-body and oversize were 28 (range = 23-36) mm and 28% (range = 21%-38%), respectively. Proximal cuff was positioned in 1 (4%) patient. Technical success was achieved in all cases. Intraoperative and perioperative morbidity and mortality were 12% and 0%, respectively. Perioperative type-I/III and II endoleaks were observed in 0 and 4 (16%) patients, respectively. The median follow-up was 12 months (range: 3-30). One patient died at 12-month for AAA-unrelated causes. Abdominal aortic aneurysm-sac shrinkage and stability were observed in 9 (36%) and 15 (60%) cases, respectively. No type-I/III endoleak and reintervention occurred during the follow-up. One persistent type-II endoleak was observed. Estimated survival at 24 months was 92%. Conclusion: According to the present data, the CEXC Device allows an excellent rate of TS in severe angulated aortic neck. This preliminary data, could increase the rate of patients eligible for EVAR.
- 23 March 2022
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 30 (3) , 410-418
Endovascular Treatment of Abdominal Aortic Aneurysm With Severe Angulation of Infrarenal Aortic Neck by Gore Conformable Endograft
Introduction: The aim of the study is to report a single-center experience with the Gore Excluder conformable endograft with active control system (CEXC Device, W.L. Gore and Associates, Flagstaff, AZ, USA) in abdominal aortic aneurysms (AAAs) with severe infrarenal neck angulation. Methods: All patients underwent EVAR with CEXC Device between September 2018 and 2020, were prospectively enrolled, and retrospectively analyzed. Anatomical details of the proximal aortic neck were evaluated. Early endpoints were the use of repositionability and angulation system, intraoperative unplanned cuff, technical success (TS), 30-day morbidity/mortality, and reintervention. Follow-up endpoints were type-I endoleaks, endograft migration, aortic neck dilatation, aneurismal sac shrinkage, survival (S), and freedom from reintervention (FFR). Results: Twenty-five patients were enrolled (median age: 80 [range = 60-90] years, median AAA diameter: 60 [range = 52-90] mm). All patients had severe infrarenal neck angulation (beta angle ≧ 60°), and 11 (44%) of those had neck beta angle ≧ 90°. Median infrarenal neck angle, length, and diameter were 70° (range = 60°-90°), 22 (range = 13-42) mm and 22 (range = 18-31) mm, respectively. Endograft repositioning system was employed in 15 (60%) cases and the median number of repositioning maneuvers was 1 (range:0-4). Active angulation system was used in 17 (68%) patients. The median proximal diameter of the main-body and oversize were 28 (range = 23-36) mm and 28% (range = 21%-38%), respectively. Proximal cuff was positioned in 1 (4%) patient. Technical success was achieved in all cases. Intraoperative and perioperative morbidity and mortality were 12% and 0%, respectively. Perioperative type-I/III and II endoleaks were observed in 0 and 4 (16%) patients, respectively. The median follow-up was 12 months (range: 3-30). One patient died at 12-month for AAA-unrelated causes. Abdominal aortic aneurysm-sac shrinkage and stability were observed in 9 (36%) and 15 (60%) cases, respectively. No type-I/III endoleak and reintervention occurred during the follow-up. One persistent type-II endoleak was observed. Estimated survival at 24 months was 92%. Conclusion: According to the present data, the CEXC Device allows an excellent rate of TS in severe angulated aortic neck. This preliminary data, could increase the rate of patients eligible for EVAR.
- Open Access
- 29 December 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 61 (5) , 1087-1096
Urgent endovascular repair of thoracoabdominal aneurysms using an off-the-shelf multibranched endograft
OBJECTIVES: Our goal was to report outcomes of the endovascular repair of urgent thoracoabdominal aortic aneurysms (TAAAs) using the Cook Zenith t-Branch off-the-shelf multibranched endograft. METHODS: Between 2010 and 2020, we collected patients with TAAAs who received an urgent endovascular repair using the Cook Zenith t-Branch (had a rupture, symptoms or diameter >80 mm). Thirty-day mortality, spinal cord ischaemia (SCI) and clinical success were assessed as early outcomes. Freedom from reintervention, target visceral vessel patency and survival were considered during follow-up. RESULTS: Sixty-five cases were managed using the Cook Zenith t-Branch for 27 (42%) TAAA ruptures, 8 (12%) symptomatic TAAAs and 30 (46%) asymptomatic TAAAs with a diameter >80 mm. Crawford’s extent I–II–III and IV were noted in 54 (83%) and 11 (17%), respectively. Eleven (17%) patients had SCI with 3 (5%) cases of permanent paraplegia. Postoperative dialysis (P = 0.04) and ruptured TAAAs (P = 0.05) were associated with SCI. Sixteen (25%) patients had reinterventions within the first 30 days postoperatively. The 30-day mortality was 14% (9). Ruptured TAAAs (P = 0.05) and technical failures (P = 0.01) were correlated with in-hospital mortality. Clinical success was 78% (51 patients). The mean follow-up was 18 ± 14 months. Survival at 24 months was 47% with no late TAAA-related deaths. Patients with ruptured TAAAs had lower survival than those who did not have ruptured TAAAs (52% vs 60% at 1 year; P = 0.05). Target visceral vessel patency and freedom from reintervention at 24 months were 89% and 60%, respectively. CONCLUSIONS: An off-the-shelf multibranched endograft is safe and effective for treating urgent TAAAs. Postoperative SCI and 30-day mortality are satisfactory for this challenging clinical scenario. The early reintervention rate is not negligible. Midterm survival is low, especially in patients with a ruptured TAAA; therefore, accurate patient selection is mandatory.
- 29 December 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 61 (5) , 1087-1096
Open AccessUrgent endovascular repair of thoracoabdominal aneurysms using an off-the-shelf multibranched endograft
OBJECTIVES: Our goal was to report outcomes of the endovascular repair of urgent thoracoabdominal aortic aneurysms (TAAAs) using the Cook Zenith t-Branch off-the-shelf multibranched endograft. METHODS: Between 2010 and 2020, we collected patients with TAAAs who received an urgent endovascular repair using the Cook Zenith t-Branch (had a rupture, symptoms or diameter >80 mm). Thirty-day mortality, spinal cord ischaemia (SCI) and clinical success were assessed as early outcomes. Freedom from reintervention, target visceral vessel patency and survival were considered during follow-up. RESULTS: Sixty-five cases were managed using the Cook Zenith t-Branch for 27 (42%) TAAA ruptures, 8 (12%) symptomatic TAAAs and 30 (46%) asymptomatic TAAAs with a diameter >80 mm. Crawford’s extent I–II–III and IV were noted in 54 (83%) and 11 (17%), respectively. Eleven (17%) patients had SCI with 3 (5%) cases of permanent paraplegia. Postoperative dialysis (P = 0.04) and ruptured TAAAs (P = 0.05) were associated with SCI. Sixteen (25%) patients had reinterventions within the first 30 days postoperatively. The 30-day mortality was 14% (9). Ruptured TAAAs (P = 0.05) and technical failures (P = 0.01) were correlated with in-hospital mortality. Clinical success was 78% (51 patients). The mean follow-up was 18 ± 14 months. Survival at 24 months was 47% with no late TAAA-related deaths. Patients with ruptured TAAAs had lower survival than those who did not have ruptured TAAAs (52% vs 60% at 1 year; P = 0.05). Target visceral vessel patency and freedom from reintervention at 24 months were 89% and 60%, respectively. CONCLUSIONS: An off-the-shelf multibranched endograft is safe and effective for treating urgent TAAAs. Postoperative SCI and 30-day mortality are satisfactory for this challenging clinical scenario. The early reintervention rate is not negligible. Midterm survival is low, especially in patients with a ruptured TAAA; therefore, accurate patient selection is mandatory.
- 1 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 76, 293-301
Tailored Sac Embolization During EVAR for Preventing Persistent Type II Endoleak
- 1 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 76, 293-301
Tailored Sac Embolization During EVAR for Preventing Persistent Type II Endoleak
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , e52-e53
Intracranial Hemorrhage After Endovascular Repair of Thoraco-abdominal Aortic Aneurysm
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , e52-e53
Intracranial Hemorrhage After Endovascular Repair of Thoraco-abdominal Aortic Aneurysm
- Open Access
- 9 September 2020
- Published by MDPI AG in Applied Sciences
- Vol. 10 (18) , 6252
EVAR-eaSE: An Easy-to-Use Software for Planning Sac Embolization in EndoVascular Aneurysm Repair Procedure
Background: Endovascular aneurysm repair (EVAR) has become the primary choice of treatment for abdominal aortic aneurysm (AAA) and preventive intraoperative AAA sac embolization (SE) is an effective way to reduce endoleaks after EVAR. Preoperative planning of AAA SE has not been standardized yet, and typically requires a quite long and operator-dependent procedure using standard EVAR planning software. Methods: We introduce ‘EVAR-eaSE’, a software tool that we have developed to help vascular surgeons to plan the optimal SE procedure during EVAR, providing semi-automatic AAA segmentation and 3D modeling starting from patient scans, and then computing the aneurysm volumes. A preliminary accuracy evaluation on radiological phantoms, and a comparison with the commercial 3Mensio software for EVAR planning are carried out. Results: EVAR-eaSE software showed a good level of accuracy in aneurysm volume reconstruction and calculation (mean difference of 2.5% between real and segmented phantom volumes). A strong positive correlation (r = 0.940, r = 0.954, p < 0.001) was found between EVAR-eaSE computation of AAA Lumen and AAA Total volumes and the same measurements obtained with 3Mensio, for a database of 26 AAA cases. Conclusions: EVAR-eaSE demonstrated to be an easy-to-use, objective and accurate tool to assist the vascular surgeons in preoperative planning of SE during EVAR.
- 9 September 2020
- Published by MDPI AG in Applied Sciences
- Vol. 10 (18) , 6252
Open AccessEVAR-eaSE: An Easy-to-Use Software for Planning Sac Embolization in EndoVascular Aneurysm Repair Procedure
Background: Endovascular aneurysm repair (EVAR) has become the primary choice of treatment for abdominal aortic aneurysm (AAA) and preventive intraoperative AAA sac embolization (SE) is an effective way to reduce endoleaks after EVAR. Preoperative planning of AAA SE has not been standardized yet, and typically requires a quite long and operator-dependent procedure using standard EVAR planning software. Methods: We introduce ‘EVAR-eaSE’, a software tool that we have developed to help vascular surgeons to plan the optimal SE procedure during EVAR, providing semi-automatic AAA segmentation and 3D modeling starting from patient scans, and then computing the aneurysm volumes. A preliminary accuracy evaluation on radiological phantoms, and a comparison with the commercial 3Mensio software for EVAR planning are carried out. Results: EVAR-eaSE software showed a good level of accuracy in aneurysm volume reconstruction and calculation (mean difference of 2.5% between real and segmented phantom volumes). A strong positive correlation (r = 0.940, r = 0.954, p < 0.001) was found between EVAR-eaSE computation of AAA Lumen and AAA Total volumes and the same measurements obtained with 3Mensio, for a database of 26 AAA cases. Conclusions: EVAR-eaSE demonstrated to be an easy-to-use, objective and accurate tool to assist the vascular surgeons in preoperative planning of SE during EVAR.